Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 9361–9380 of 17,529 recalls

February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levetiracetam USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Doxycycline Hyclate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Verapamil HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Ketoconazole USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Biotin USP (Vitamin H) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Tacrolimus USP (Monohydrate) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Ketamine HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Methylcobalamin (Vitamin B12) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Clonidine HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Nandrolone Decanoate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Tretinoin USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Desoximetasone USP (Micronized) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Cyanocobalamin USP (Vitamin B12) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Stanozolol USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sumatriptan Succinate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Leucovorin Calcium USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Diclofenac Sodium USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Liothyronine Sodium USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Gabapentin USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levothyroxine Sodium USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund